BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND TPR, P12270, 7175
27 results:

  • 1. [Prognostic Value of Average Daily Platelet Increase in Childhood B-cell Acute Lymphoblastic Leukemia Patients].
    Chen L; Chen Q; Wang YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):413-417. PubMed ID: 35395972
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma-data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin's lymphoma Study Group).
    Zettl F; Ziepert M; Altmann B; Zeynalova S; Held G; Pöschel V; Hohloch K; Wulf GG; Glass B; Schmitz N; Loeffler M; Trümper L
    Ann Hematol; 2021 Apr; 100(4):1031-1038. PubMed ID: 33242101
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutual Information based hybrid model and deep learning for Acute Lymphocytic Leukemia detection in single cell blood smear images.
    Jha KK; Dutta HS
    Comput Methods Programs Biomed; 2019 Oct; 179():104987. PubMed ID: 31443862
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A population-based multistate model for diffuse large B-cell lymphoma-specific mortality in older patients.
    Çağlayan Ç; Goldstein JS; Ayer T; Rai A; Flowers CR
    Cancer; 2019 Jun; 125(11):1837-1847. PubMed ID: 30707765
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Increased
    Okuyama C; Matsushima S; Nishimura M; Yamada K
    Ann Nucl Med; 2019 May; 33(5):368-373. PubMed ID: 30689118
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical value of the quantitation of average daily platelet increase during the recovery period in childhood acute lymphoblastic leukaemia.
    Wang Y; Zhang G; Ye L; Dai Q; Peng L; Chen L; Chen Q; Jiang Y; Gao J
    Platelets; 2019; 30(7):923-926. PubMed ID: 30497316
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [MicroRNA-138 regulates cell adhesion-mediated drug resistance phenotype by targeting SGTA in non-Hodgkin's lymphoma].
    Wu YX; He S; Xu XH
    Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):668-673. PubMed ID: 30180469
    [No Abstract]    [Full Text] [Related]  

  • 8. Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including
    Latifoltojar A; Punwani S; Lopes A; Humphries PD; Klusmann M; Menezes LJ; Daw S; Shankar A; Neriman D; Fitzke H; Clifton-Hadley L; Smith P; Taylor SA
    Eur Radiol; 2019 Jan; 29(1):202-212. PubMed ID: 29948084
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular dynamics simulations of site point mutations in the tpr domain of cyclophilin 40 identify conformational states with distinct dynamic and enzymatic properties.
    Gur M; Blackburn EA; Ning J; Narayan V; Ball KL; Walkinshaw MD; Erman B
    J Chem Phys; 2018 Apr; 148(14):145101. PubMed ID: 29655319
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ALK-rearrangement in non-small-cell lung cancer (NSCLC).
    Du X; Shao Y; Qin HF; Tai YH; Gao HJ
    Thorac Cancer; 2018 Apr; 9(4):423-430. PubMed ID: 29488330
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Acute Leukemia of Ambiguous Lineage in Elderly Patients - Analysis of Survival Using Surveillance Epidemiology and End Results-Medicare Database.
    Guru Murthy GS; Dhakal I; Lee JY; Mehta P
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):100-107. PubMed ID: 27998706
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions.
    Yeh I; de la Fouchardiere A; Pissaloux D; Mully TW; Garrido MC; Vemula SS; Busam KJ; LeBoit PE; McCalmont TH; Bastian BC
    Am J Surg Pathol; 2015 May; 39(5):581-91. PubMed ID: 25602801
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular identification of a tpr-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
    Kim SY; Kim JE; Park S; Kim HK
    Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of small glutamine-rich tpr-containing protein A (SGTA) in Non-Hodgkin's lymphomas promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR).
    Wang Y; Huang Y; Xu X; Tang J; Huang X; Zhu J; Liu J; Miao X; Wu Y; Yang F; Ji L; He S
    Leuk Res; 2014 Aug; 38(8):955-63. PubMed ID: 24974147
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A novel fusion of tpr and ALK in lung adenocarcinoma.
    Choi YL; Lira ME; Hong M; Kim RN; Choi SJ; Song JY; Pandy K; Mann DL; Stahl JA; Peckham HE; Zheng Z; Han J; Mao M; Kim J
    J Thorac Oncol; 2014 Apr; 9(4):563-6. PubMed ID: 24736082
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HTLV-I Tax-dependent and -independent events associated with immortalization of human primary T lymphocytes.
    Bellon M; Baydoun HH; Yao Y; Nicot C
    Blood; 2010 Mar; 115(12):2441-8. PubMed ID: 20093405
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
    Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G
    Blood; 2009 Mar; 113(12):2776-90. PubMed ID: 18845790
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An in vivo model of Met-driven lymphoma as a tool to explore the therapeutic potential of Met inhibitors.
    Accornero P; Lattanzio G; Mangano T; Chiarle R; Taulli R; Bersani F; Forni PE; Miretti S; Scuoppo C; Dastrù W; Christensen JG; Crepaldi T; Ponzetto C
    Clin Cancer Res; 2008 Apr; 14(7):2220-6. PubMed ID: 18381964
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.
    Ma PC; Schaefer E; Christensen JG; Salgia R
    Clin Cancer Res; 2005 Mar; 11(6):2312-9. PubMed ID: 15788682
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evaluation of kidney damage in patients with acute lymphoblastic leukemia in long-term follow-up: value of renal scan.
    Yetgin S; Olgar S; Aras T; Cetin M; Düzova A; Beylergil V; Akhan O; Oĝuz O; Saraçbaşi O
    Am J Hematol; 2004 Oct; 77(2):132-9. PubMed ID: 15389822
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.